Table 1

Clinical characteristics and biochemical evaluation of control subjects (CG) and of patients with postsurgical hypoparathyroidism (PhPTG)
CG (n = 17) PhPTG (n = 16) Estimated difference p-value
[C.I.(95%)]
Age (year) 58.0 ± 6.1 62.3 ± 8.9 −4.31(−9.69;1.06) P = 0.2
Weight(kg) 71.8 ± 13.7 72.6 ± 10.9 −0,82(−9.63;7.98) P = 0.9
Height (m) 1.58 ± 6.4 1.54 ± 7.9 4.18(−0.95;9.31) P = 0.8
BMI (kg/m2) 28.5 ± 5.5 30.3 ± 4.2 −1.84(−5.33;1.65) P = 0.4
Duration of PhPT - 15.3 ± 12.4
Total calcium (mmol/L) 2.43 ± 0.13* 2.05 ± 0.21 1.45(0.95;1.96) P <0.0001
Ca X Pi 3.11 ± 0.63 3.21 ± 0.59 −1.15(−6.51;4.21) P = 0.50
Albumin (g/L) 44.1 ± 2.4* 42.3 ± 1.8 0.18(0.02;0.33) P < 0.05
Phosphorus (mmol/L) 1.29 ± 0.22* 1.57 ± 0.32 −0.86(−1.46;-0.27) P < 0.05
Alkaline phosphatase (U/L) 235.4 ± 65.8 198.1 ± 37.14 37.29(−1;75.58) P = 0.09
Creatinine (μmol/L) 57.96 ± 7.63* 69.39 ± 21.35 −0.30(−0.15;-0.005) P < 0.05
PTH (ng/L) 42.0 ± 18.7* 5.9 ± 4.6 36.05(26.23;45.88) P < 0.0001
25-hydroxyvitamin D (nmol/L) 82.0 ± 35.02 100.8 ± 31.47 −18.9(−42.6;4.85) P = 0.11
IGF-I (μg/L) 68.76 ± 43.55 51.94 ± 19.15 16.83(−7.33;40.98) P = 0.53

Mendonça et al.

Mendonça et al. BMC Endocrine Disorders 2013 13:1   doi:10.1186/1472-6823-13-1

Open Data